Education
About Us
Working with TipRanks
Follow Us
Polarean Imaging Plc (PLLWF)
:PLLWF
PLLWF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.04
Previous CloseN/A
Volume15.00K
Average Volume (3M)666.00
Market Cap
$15.16M
Enterprise Value-$7.25M
Total Cash (Recent Filing)$9.88M
Total Debt (Recent Filing)$147.67K
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Jun 26, 2025Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding1,207,032,800
10 Day Avg. Volume2,000
30 Day Avg. Volume666
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)10.24
Price to Cash Flow (P/CF)-3.80
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.48
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-21.62
Enterprise Value/Ebitda0.53
Forecast
1Y Price Target
$0.10Price Target Upside400.00% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Polarean Imaging News
PremiumCompany Announcements
Polarean Expands Xenon MRI Platform for Pharma Research
PremiumCompany Announcements
Polarean Imaging Exceeds FY24 Revenue Targets and Expands Global ReachPremiumCompany Announcements
Polarean Imaging to Host Virtual Investor Day Highlighting MRI Innovations
PremiumCompany Announcements
Polarean Expands Internationally with Taiwanese Distribution Deal
PremiumCompany Announcements
Polarean Imaging Secures Key Patent in China for Xenon MRI Technology
PremiumCompany Announcements
Polarean Imaging and SimonMed Collaborate to Enhance Lung Imaging
PremiumCompany Announcements
Amati Global Investors Reduces Stake in Polarean Imaging---
Bulls Say, Bears Say
Bulls Say
Market ExpansionPolarean has signed a distribution agreement with Sumtage Enterprise for the distribution of Polarean’s Xenon MRI platform in Taiwan, marking Polarean's entry into the Taiwanese market.
Strategic CollaborationPolarean has signed a strategic collaboration with SimonMed Imaging, one of the largest outpatient medical imaging providers in the US.
Bears Say
Commercial Roll-OutA potential commercial roll-out in Taiwan seems unlikely until the second half of 2026.
---
Options Prices
Currently, No data available
---
Ownership Overview
PLLWF FAQ
What was Polarean Imaging Plc’s price range in the past 12 months?
Polarean Imaging Plc lowest stock price was $0.01 and its highest was $0.04 in the past 12 months.
What is Polarean Imaging Plc’s market cap?
Polarean Imaging Plc’s market cap is $15.16M.
When is Polarean Imaging Plc’s upcoming earnings report date?
Polarean Imaging Plc’s upcoming earnings report date is Jun 26, 2025 which is in 80 days.
How were Polarean Imaging Plc’s earnings last quarter?
Polarean Imaging Plc released its earnings results on Sep 04, 2024. The company reported -$0.014 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.014.
Is Polarean Imaging Plc overvalued?
According to Wall Street analysts Polarean Imaging Plc’s price is currently Undervalued.
Does Polarean Imaging Plc pay dividends?
Polarean Imaging Plc does not currently pay dividends.
What is Polarean Imaging Plc’s EPS estimate?
Polarean Imaging Plc’s EPS estimate is 0.
How many shares outstanding does Polarean Imaging Plc have?
Polarean Imaging Plc has 1,207,032,800 shares outstanding.
What happened to Polarean Imaging Plc’s price movement after its last earnings report?
Polarean Imaging Plc reported an EPS of -$0.014 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Polarean Imaging Plc?
Currently, no hedge funds are holding shares in PLLWF
---
Company Description
Polarean Imaging Plc
Polarean Imaging plc operates as a medical drug-device combination company serving the medical imaging market in the United States, Canada, Germany, and the United Kingdom. The company engages in the development and commercialization of gas polarizer devices and ancillary instruments. It develops equipment that enables existing magnetic resonance imaging (MRI) systems to achieve a level of pulmonary functional imaging and specializes in the use of hyperpolarized xenon gas (129Xe) as an imaging agent to visualize ventilation and gas exchange regionally in the smallest airways of the lungs, the tissue barrier between the lung and the bloodstream, and in the pulmonary vasculature; and a novel diagnostic approach. The company is also involved in the development and manufacture of MRI radiofrequency coils, which are required components for imaging 129Xe in the MRI system. Polarean Imaging plc was incorporated in 2016 and is based in Durham, North Carolina.
---
PLLWF Stock 12 Month Forecast
Average Price Target
$0.10
▲(400.00% Upside)
Technical Analysis
Creo Medical
―
EKF Diagnostics Holdings
―
Nanoco Group plc
―
Renalytix
―
Trellus Health PLC
―
Best Analysts Covering PLLWF
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-62.85%
reiterated a buy rating 2 months ago
Copying Christian Glennie's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -62.85% per trade.
---